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 Supplementary oxygen in acute STEMI: no added 
benefit rather than potential for harm  
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The use of high-flow oxygen in the setting of acute myocardial infarction 
remains controversial. We therefore read with great interest the randomized 
controlled clinical trial by Stub et al1, which investigated the effect of 
supplementary oxygen versus air in normoxic patients presenting with an 
acute ST-segment elevation myocardial infarction (STEMI). In their study, the 
authors concluded that supplementary oxygen therapy may increase early 
myocardial injury and was associated with larger myocardial infarct size 
assessed by cardiovascular magnetic resonance (CMR) at 6 months in 
STEMI patients. However, the data provided in the study do not appear to 
support this conclusion.  Firstly, it was based on a difference in peak levels of 
serum CK between the two groups. However, CK is known to be less specific 
for myocardial necrosis2, and the study had not been originally powered to 
detect this endpoint. The authors had actually powered the study based on 
peak levels of serum troponin I, a more specific biomarker for myocardial 
necrosis than CK, and for which there was no significant difference between 
the 2 groups. Secondly, they reported a difference in myocardial infarct MI 
size at 6 months in grams measured by CMR, but when this was normalized 
to left ventricular (LV) mass, there was no significant difference between the 
two groups. In the absence of T2-weighted CMR imaging to quantify the area-
at-risk (AAR), the authors could have used coronary angiographic jeopardy 
scores to estimate the AAR and calculate myocardial salvage3, 4, an approach 
which has previously been used to validate T2-weighted CMR imaging.  In 
summary, the data do not appear to support the conclusion that supplemental 
oxygen may be harmful in normoxic STEMI patients when compared to air – 
rather it shows no added benefit with this therapeutic approach. 
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